|
Neglected
no more
There is a renewed focus on rare diseases and neglected tropical
diseases, thanks to incentives offered under the US Orphan
Drug Legislation and its extension, the Priority Review Voucher
scheme. What are the new business models emerging from this
strategy shift? Viveka Roychowdhury analyses
Affordable
Healthcare -Role of pharmaceutical industry
Dr. Ajit Dangi, President & CEO, Danssen Consulting opines
that the pharma industry should re-prioritise and cocus more
on delivering affordable healthcare in India
|
